The Valley Desk

NCT01672866 · Interventional trial

Safety and Efficacy of Simtuzumab (SIM, GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)

Overall registry status Terminated

Phase 2

Conditions Liver Fibrosis Due to NASH

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov